| A pilot study of omalizumab in eosinophilic esophagitis D Loizou, B Enav, E Komlodi-Pasztor, P Hider, J Kim-Chang, L Noonan, ... PloS one 10 (3), e0113483, 2015 | 152 | 2015 |
| Hepatitis C virus internal ribosome entry site-mediated translation is stimulated by specific interaction of independent regions of human La autoantigen R Pudi, S Abhiman, N Srinivasan, S Das Journal of Biological Chemistry 278 (14), 12231-12240, 2003 | 106 | 2003 |
| Efficient procurement of epithelial stem cells from human tissue specimens using a Rho-associated protein kinase inhibitor Y-27632 A Terunuma, RP Limgala, CJ Park, I Choudhary, JC Vogel Tissue Engineering Part A 16 (4), 1363-1368, 2010 | 91 | 2010 |
| La protein binding at the GCAC site near the initiator AUG facilitates the ribosomal assembly on the hepatitis C virus RNA to influence internal ribosome entry site-mediated … R Pudi, P Srinivasan, S Das Journal of Biological Chemistry 279 (29), 29879-29888, 2004 | 76 | 2004 |
| Gaucheromas: when macrophages promote tumor formation and dissemination M Ivanova, RP Limgala, E Changsila, R Kamath, C Ioanou, ... Blood Cells, Molecules, and Diseases 68, 100-105, 2018 | 38 | 2018 |
| Time of initiating enzyme replacement therapy affects immune abnormalities and disease severity in patients with Gaucher disease RP Limgala, C Ioanou, M Plassmeyer, M Ryherd, L Kozhaya, L Austin, ... PloS one 11 (12), e0168135, 2016 | 34 | 2016 |
| A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal … R Pudi, SS Ramamurthy, S Das Journal of virology 79 (15), 9842-9853, 2005 | 33 | 2005 |
| Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease SU Sønder, RP Limgala, MM Ivanova, C Ioanou, M Plassmeyer, GE Marti, ... Blood Cells, Molecules, and Diseases 59, 8-15, 2016 | 24 | 2016 |
| Leader RNA of Rinderpest virus binds specifically with cellular La protein: a possible role in virus replication T Raha, R Pudi, S Das, MS Shaila Virus research 104 (2), 101-109, 2004 | 23 | 2004 |
| Human ribosomal protein L18a interacts with hepatitis C virus internal ribosome entry site D Dhar, K Mapa, R Pudi, P Srinivasan, K Bodhinathan, S Das Archives of virology 151, 509-524, 2006 | 21 | 2006 |
| Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher Disease RP Limgala, O Goker-Alpan Biomolecules 10 (4), 526, 2020 | 13 | 2020 |
| Altered immune phenotypes in subjects with Fabry disease and responses to switching from agalsidase alfa to agalsidase beta RP Limgala, T Jennelle, M Plassmeyer, M Boutin, P Lavoie, M Abaoui, ... American journal of translational research 11 (3), 1683, 2019 | 12 | 2019 |
| Pregnancy outcomes in late onset Pompe disease O Goker-Alpan, VG Kasturi, MK Sohi, RP Limgala, SL Austin, T Jennelle, ... Life 10 (9), 194, 2020 | 9 | 2020 |
| Enzyme replacement therapy reverses B lymphocyte and dendritic cell dysregulations in patients with Gaucher disease RP Limgala, C Jani, C Ioanou, O Alpan, O Goker-Alpan Blood Cells, Molecules, and Diseases 68, 81-85, 2018 | 5 | 2018 |
| Selective screening for lysosomal storage disorders in a large cohort of minorities of African descent shows high prevalence rates and novel variants RP Limgala, V Furtak, MM Ivanova, E Changsila, F Wilks, ... JIMD reports 59 (1), 60-68, 2021 | 4 | 2021 |
| Biofabrication of an in-vitro bone model for Gaucher disease D Banerjee, MM Ivanova, N Celik, MH Kim, ID Derman, RP Limgala, ... Biofabrication 15 (4), 045023, 2023 | 2 | 2023 |
| The Interaction of Innate and Adaptive Immunity and Stabilization of Mast Cell Activation in Management of Infusion Related Reactions in Patients with Fabry Disease RP Limgala, J Fikry, V Veligatla, O Goker-Alpan International Journal of Molecular Sciences 21 (19), 7213, 2020 | 2 | 2020 |
| Alpha-synuclein in peripheral blood mononuclear cells as biomarker for synucleinopathy RP Limgala, O Goker-alpan US Patent App. 16/321,242, 2019 | 2 | 2019 |
| Evaluation of disease burden and therapy modifications using glucosylsphingosine (lyso-GL1) in Gaucher disease J Dao, O Goker-Alpan, R Limgala Molecular Genetics and Metabolism 126 (2), S45, 2019 | 2 | 2019 |
| Role of non-classical monocytes in Gaucher disease severity RP Limgala, C Ioanou, O Alpan, O Goker-Alpan Molecular Genetics and Metabolism 2 (114), S73-S74, 2015 | 2 | 2015 |
